IDEXX Laboratories Operating Margin 2010-2025 | IDXX

IDEXX Laboratories operating margin for the quarter ending March 31, 2025 was 29.17%.

  • IDEXX Laboratories average operating margin for 2024 was 29.1%, a 0.44% increase from 2023.
  • IDEXX Laboratories average operating margin for 2023 was 29.23%, a 9.31% decline from 2022.
  • IDEXX Laboratories average operating margin for 2022 was 26.74%, a 6.63% increase from 2021.

Operating margin can be defined as operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc.

IDEXX Laboratories Operating Margin 2010-2025 | IDXX

  • IDEXX Laboratories average operating margin for 2024 was 29.1%, a 0.44% increase from 2023.
  • IDEXX Laboratories average operating margin for 2023 was 29.23%, a 9.31% decline from 2022.
  • IDEXX Laboratories average operating margin for 2022 was 26.74%, a 6.63% increase from 2021.

Operating margin can be defined as operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$182B
Intuitive Surgical (ISRG)$178.1B
Edwards Lifesciences (EW)$47.2B
Alcon (ALC)$45.1B
DexCom (DXCM)$35B
IQVIA Holdings (IQV)$33.1B
Mettler-Toledo (MTD)$26.3B
STERIS (STE)$22.5B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.2B
Hologic (HOLX)$14.7B
Sysmex ADR (SSMXY)$10.6B
Penumbra (PEN)$8.8B
Masimo (MASI)$8.6B
Globus Medical (GMED)$7.3B
Glaukos (GKOS)$5.4B
Teleflex (TFX)$5.1B
Integer Holdings (ITGR)$3.8B
TransMedics (TMDX)$3.5B
PROCEPT BioRobotics (PRCT)$3B
LivaNova (LIVN)$2.4B
Nihon Kohden (NHNKY)$2B
Elekta AB (EKTAY)$1.9B
Veracyte (VCYT)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Tandem Diabetes Care (TNDM)$1.1B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Integra LifeSciences Holdings (IART)$999M